NATURAL HEALTH TRENDS CORP(NASDAQ:NHTC) stock Fundamental Analysis

Fundamental Rating

NHTC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. NHTC has a great financial health rating, but its profitability evaluates not so good. NHTC has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NHTC was profitable.

In the past year NHTC has reported a negative cash flow from operations.

Each year in the past 5 years NHTC has been profitable.

In multiple years NHTC reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of NHTC (1.29%) is comparable to the rest of the industry.

Looking at the Return On Equity, with a value of 2.14%, NHTC is in the better half of the industry, outperforming 61.11% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	1.29%
ROE	2.14%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NHTC has a Profit Margin (1.75%) which is in line with its industry peers.

NHTC's Profit Margin has declined in the last couple of years.

Looking at the Gross Margin, with a value of 74.07%, NHTC belongs to the top of the industry, outperforming 86.11% of the companies in the same industry.

NHTC's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	1.75%
GM	74.07%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-10.12%

PM growth 5YN/A

GM growth 3Y-0.45%

GM growth 5Y-0.03%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.

NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.21 indicates that NHTC is not a great score, but indicates only limited risk for bankruptcy at the moment.

NHTC's Altman-Z score of 2.21 is in line compared to the rest of the industry. NHTC outperforms 47.22% of its industry peers.

NHTC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.21

ROIC/WACCN/A

WACC9.06%

2.3 Liquidity

A Current Ratio of 2.55 indicates that NHTC has no problem at all paying its short term obligations.

NHTC has a Current ratio of 2.55. This is in the better half of the industry: NHTC outperforms 66.67% of its industry peers.

A Quick Ratio of 2.38 indicates that NHTC has no problem at all paying its short term obligations.

NHTC's Quick ratio of 2.38 is fine compared to the rest of the industry. NHTC outperforms 77.78% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.55
Quick Ratio	2.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NHTC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite good.

Measured over the past years, NHTC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.79% on average per year.

Looking at the last year, NHTC shows a decrease in Revenue. The Revenue has decreased by -2.19% in the last year.

NHTC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.15% yearly.

EPS 1Y (TTM)20%

EPS 3Y-17.79%

EPS 5YN/A

EPS Q2Q%-33.33%

Revenue 1Y (TTM)-2.19%

Revenue growth 3Y-10.54%

Revenue growth 5Y-11.15%

Sales Q2Q%-0.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 79.83 indicates a quite expensive valuation of NHTC.

NHTC's Price/Earnings is on the same level as the industry average.

When comparing the Price/Earnings ratio of NHTC to the average of the S&P500 Index (29.62), we can say NHTC is valued expensively.

		Industry Rank	Sector Rank
PE	79.83
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 16.95%, NHTC is a good candidate for dividend investing.

NHTC's Dividend Yield is rather good when compared to the industry average which is at 5.09. NHTC pays more dividend than 100.00% of the companies in the same industry.

Compared to an average S&P500 Dividend Yield of 2.27, NHTC pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	16.95%

5.2 History

The dividend of NHTC decreases each year by -21.95%.

NHTC has paid a dividend for at least 10 years, which is a reliable track record.

NHTC has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)-21.95%

Div Incr Years0

Div Non Decr Years10

5.3 Sustainability

1222.02% of the earnings are spent on dividend by NHTC. This is not a sustainable payout ratio.

DP1222.02%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (2/21/2025, 8:00:01 PM)

After market: 4.48 -0.31 (-6.47%)

4.79

+0.07 (+1.48%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)02-05 2025-02-05/bmo

Earnings (Next)04-29 2025-04-29

Inst Owners10.09%

Inst Owner Change-100%

Ins Owners15.6%

Ins Owner Change0%

Market Cap55.13M

Analysts0

Price TargetN/A

Short Float %0.38%

Short Ratio1.15

Dividend

		Industry Rank	Sector Rank
Dividend Yield	16.95%

Yearly Dividend0.8

Dividend Growth(5Y)-21.95%

DP1222.02%

Div Incr Years0

Div Non Decr Years10

Ex-Date02-18 2025-02-18 (0.2)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	79.83
Fwd PE	N/A
P/S	1.28
P/FCF	N/A
P/OCF	N/A
P/B	1.56
P/tB	1.56
EV/EBITDA	N/A

EPS(TTM)0.06

EY1.25%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.31

FCFYN/A

OCF(TTM)-0.31

OCFYN/A

SpS3.74

BVpS3.07

TBVpS3.07

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.29%
ROE	2.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	1.75%
GM	74.07%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-10.12%

PM growth 5YN/A

GM growth 3Y-0.45%

GM growth 5Y-0.03%

F-Score4

Asset Turnover0.74

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	39.55%
Cap/Sales	0.12%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.55
Quick Ratio	2.38
Altman-Z	2.21

F-Score4

WACC9.06%

ROIC/WACCN/A

Cap/Depr(3y)47.19%

Cap/Depr(5y)53.89%

Cap/Sales(3y)0.17%

Cap/Sales(5y)0.25%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)20%

EPS 3Y-17.79%

EPS 5YN/A

EPS Q2Q%-33.33%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.19%

Revenue growth 3Y-10.54%

Revenue growth 5Y-11.15%

Sales Q2Q%-0.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y18.84%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-8.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-7.74%

OCF growth 3YN/A

OCF growth 5YN/A

NATURAL HEALTH TRENDS CORP (NHTC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens